Levilimab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Levilimab, covering 2021-11-18 to 2023-04-05. Get the full timeline:
Most recent: Clinical Trial Update: A Two-Stage Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Various Doses of Levilimab When Administered Intravenously and Subcutaneously to Healthy Subjects and Subjects With Active Rheumatoid Arthritis [Phase 3]